TGFB1 and neoplasm: Noncanonical pathways include RhoA/ROCK1, PI3K/Akt, Wnt/β-catenin, MAPK/p38, or MAPK ERK1/2, all of which mediate different effects of TGF-β on tumor cells35,45,46.